A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics

NCT05970978 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: regular treatment
DRUG: Intensive treatment

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.